IOIbrahim Omeis

Ibrahim Omeis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ibrahim Omeis has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Retained foreign needle in the thoracic spinal canal in a child: Case report

    by Sarah Kawtharani, Shadi Abdelatif Bsat, Mohamad El Houshiemy, Charbel Moussalem, Adham Halaoui, Ibrahim Omeis

    Background: The presence of retained foreign bodies in the spinal canal has been reported in the literature. They are attributed to retained pieces of medical equipment after surgery, or, following trauma, to residual bullets, glass fragments, or knife blades. Although some retained materials do not cause any neurological deficits in the short run, others may become symptomatic months later. Case Description: A 2-year-old male presented with a history of intermittent fever and mild lower extremity weakness. Notably, the original infectious workup was negative. However, a noncontrast CT scan later documented a needle-shaped foreign body in the spinal canal at the T10 level. During the T10 laminectomy, a needle (i.e. from a medical syringe) was removed, the patient remained neurologically intact. The foreign body turned out to be a medical syringe needle tip. Conclusion: A 2-year-old male presented with fevers and mild lower extremity weakness attributed to an intraspinal needle tip found utilizing CT at the T10 level. T10 laminectomy allowed for removal of a small needle tip. This shows the importance of removing retained spinal foreign bodies to avoid further/future neurological injury, and/or the potential risks/complications of foreign body migration/sequestration.


  • Open Access

    Effect of Phase Change Material Cooling Vests on Body Thermoregulation and Thermal Comfort of Patients With Paraplegia: A Human Subject Experimental Study

    by Charbel K. Moussalem, Farah Mneimneh, Rana Sarieddine, Shadi Bsat, Mohamad N. El Houshiemy, Georges B. Minassian, Nesreen Ghaddar, Kamel Ghali, Ibrahim Omeis

    Study design: Randomized experimental study. Objective: Compared to able-bodied people, patients with paraplegia due to thoracic spinal cord injury (SCI) are at an increased risk of heat illnesses during exercise due to impaired thermoregulatory responses. To overcome this limitation, we investigated the performance of three phase change material (PCM) cooling vests of different melting temperatures (Eijsvogels, #49) and coverage area of the trunk. Methods: Sixteen participants were divided into three groups according to their injury level. All were tested for V20 full vest (20°C Tm, 75% coverage). Mid-thoracic and high-thoracic groups were tested for V14 vest (14°C Tm, 75% coverage). The mid-thoracic group was tested for V20 half vest (20°C Tm, 50% coverage). The participants performed a 30-min arm-crank exercise followed by a recovery period inside a controlled hot climatic chamber. The heart rate, segmental skin (Tskin), and core temperature (Tcore) values were recorded, and subjective questionnaires were taken. Results: Compared to no vest (NV) test, all the vests showed an effective decrease in Tskin values of the trunk. However, the decrease in Tskin was not enough to induce a significant decrease in Tcore in all three groups. Mid-thoracic and low-thoracic groups showed a reduction in the increasing Tcore by the end of the exercise and recovery period. Finally, the level of thermal comfort was enhanced for the three groups. Conclusion: The effectiveness of cooling vests for persons with paraplegia is dependent on injury level and thus the ratio of sensate to insensate skin. Future studies necessitate the investigation of the cooling effects of PCM vests at a lower Tm with a larger sample size.


  • Negative pharmacological effect on spine fusion: A narrative review of the literature of evidence-based treatment

    by Charbel Moussalem, Louna Ftouni, Zaki Abou Mrad, Shadi Bsat, Mohamad Houshiemy, Safwan Alomari, Ibrahim Omeis


  • Open Access

    Experiment Study for Evaluation of Phase Change Material Cooling Vest\u2019s Effectiveness at Two Melting Points Used by People With Paraplegia During Exercise

    by Farah Mneimneh, Charbel Moussalem, Nesreen Ghaddar, Kamel Ghali, Ibrahim Omeis

    Phase change material (PCM) cooling vests were tested on people with thoracic (T1-T12) spinal cord injury (SCI), also called people with paraplegia (PA), during exercise and hot exposure. This cooling method application was uprising upon the increased awareness and public health concern for people with SCI. The aim was to reduce heat stress, limit the increase in core temperature,

  • Open Access

    Clinical utility of degradomics as predictors of complications and clinical outcome in aneurysmal subarachnoid hemorrhage

    by Shadi Bsat, Hani Chanbour, Ayman Bsat, Safwan Alomari, Charbel Moussalem, Mohamad Nabih El Houshiemy, Ibrahim Omeis

    Most of the debilitating conditions following aneurysmal subarachnoid hemorrhage result from symptomatic cerebral vasospasm and delayed cerebral ischemia. Several scales are being used, but they still lack objectivity and fail to quantify complications considered essential for prognostication routine use of biomarkers to predict complications and outcomes after aneurysmal rupture is still experimental. Degradomics were studied extensively in traumatic brain injury, but there is no discussion of these biomarkers related to aneurysmal subarachnoid hemorrhage. Degradomics involve the activation of proteases that target specific substrates and generate specific protein fragments called degradomes. While the proteolytic activities constitute the pillar of development, growth, and regeneration of tissues, dysregulated proteolysis resulting from pathological conditions like aneurysmal subarachnoid hemorrhage ends up in apoptotic processes and necrosis. To our knowledge, this is the first overview that lists a panel of degradomics with cut-off values in serum and cerebrospinal fluid, where specificity and sensitivity are only found in Kallikrein 6, Ubiquitin C Terminal Hydrolase 1 and Alpha-II-Spectrin.


  • Open Access

    Meningioma genomics: a therapeutic challenge for clinicians

    by Charbel Moussalem, Elie Massaad, Georges B. Minassian, Louna Ftouni, Shadi Bsat, Mohamad N. El Houshiemy, Safwan Alomari, Rana Sarieddine, Firas Kobeissy, Ibrahim Omeis

    Meningiomas are amongst the most commonly encountered intracranial tumors. The majority of these tumors arise intracranially, and the remaining incidents occur along the spinal cord. Meningiomas tend to grow gradually, with many tumors arising in inaccessible locations. Such sporadic behavior poses a therapeutic challenge to clinicians, causing incomplete tumor resections that often lead to recurrence. Therefore, ongoing research seeks to find alternative systematic treatments for meningiomas, with gene-based therapeutics of high interest. Subsequently, genetic studies characterized frequent somatic mutations in NF2, TRAF7, KLF4, AKT1, SMO, and PIK3CA. These genes are communally exhibited in 80% of sporadic meningiomas. In addition, other genes such as the DUSP family, the NR4 family, CMKOR, and FOSL2, have been identified as key players in spinal meningiomas. In this perspective, we aim to investigate current genetic-based studies, with the ongoing research mainly focused on the above NF2, TRAF7, KLF4, AKT1, SMO, and PIK3CA genes and their involved pathways. In addition, this perspective can serve as a potential cornerstone for future genetic analyses of meningioma cases.


  • Open Access

    Acute ischemic stroke biomarkers: a new era with diagnostic promise?

    by Shadi Bsat, Adham Halaoui, Firas Kobeissy, Charbel Moussalem, Mohamad Nabih El Houshiemy, Sarah Kawtharani, Ibrahim Omeis

    Stroke is considered as the first cause of neurological dysfunction and second cause of death worldwide. Recombinant tissue plasminogen activator is the only chemical treatment for ischemic stroke approved by the US Food and Drug Administration. It was the only standard of care for a long time with a very narrow therapeutic window, which usually ranges from 3 to 4.5 h of stroke onset; until 2015, when multiple trials demonstrated the benefit of mechanical thrombectomy during the first 6 h. In addition, recent trials showed that mechanical thrombectomy can be beneficial up to 24 h if the patients meet certain criteria including the presence of magnetic resonance imaging/computed tomography perfusion mismatch, which allows better selectivity and higher recruitment of eligible stroke patients. However, magnetic resonance imaging/computed tomography perfusion is not available in all stroke centers. Hence, physicians need other easy and available diagnostic tools to select stroke patients eligible for mechanical thrombectomy. Moreover, stroke management is still challenging for physicians, particularly those dealing with patients with “wake‐up” stroke. The resulting brain tissue damage of ischemic stroke and the subsequent pathological processes are mediated by multiple molecular pathways that are modulated by inflammatory markers and post‐transcriptional activity. A considerable number of published works suggest the role of inflammatory and cardiac brain‐derived biomarkers (serum matrix metalloproteinase, thioredoxin, neuronal and glial markers, and troponin proteins) as well as different biomarkers including the emerging roles of microRNAs. In this review, we assess the accumulating evidence regarding the current status of acute ischemic stroke diagnostic biomarkers that could guide physicians for better management of stroke patients. Our review could give an insight into the roles of the different emerging markers and microRNAs that can be of high diagnostic value in patients with stroke. In fact, the field of stroke research, similar to the field of traumatic brain injury, is in immense need for novel biomarkers that can stratify diagnosis, prognosis, and therapy.


  • Hypothalamic Hamartomas: A Comprehensive Review of Literature – Part 3: Updates on Radiotherapy Management

    by Safwan O. Alomari, Mohammed N. El Houshiemy, Shadi Bsat, Charbel K. Moussalem, Mohammed Allouh, Ibrahim A. Omeis


  • Role of connexins in spinal cord injury: An update

    by Zaki Abou-Mrad, Safwan O. Alomari, Shadi Bsat, Charbel K. Moussalem, Khaled Alok, Mohamad N. El Houshiemy, Ahmad O. Alomari, Georges B. Minassian, Ibrahim A Omeis